Category: Food & Drug Administration (FDA)Syndicate content

FDA clears Neuronetrix portable EEG device

February 24, 2015 by Val Kennedy

The FDA has cleared Neuronetrix's portable device for the recording of electrical brainwaves in patients with neurological conditions such as Alzheimer's disease, concussion, schizophrenia and ADHD.

regular_neuronetrix.jpg

The FDA has cleared Neuronetrix's portable device for the recording of electrical brainwaves in patients with neurological conditions such as Alzheimer's disease, concussion, schizophrenia and ADHD.

The device, called the Cognision System, is designed to run brainwave tests such as EEGs and auditory event-related potentials (ERPs). Neuronetrix said the device allows doctors to run tests in their offices that used to be only available in a hospital setting.